Exhibit 10.6 Warrant Agreement dated June 30, 1998 between Neurocrine Biosciences, Inc., a Delaware corporation (the "Company"), and Stephen L. Ross ("Holder"). Whereas Holder and the Company are parties to a certain Sublicense and Development...Warrant Agreement • August 14th, 1998 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances)
ANDAgreement and Plan of Reorganization • August 14th, 1998 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • California
Exhibit 10.2 PASTAN/FITZGERALD AND NEUROCRINE BIOSCIENCES, INC. PATENT LICENSE AGREEMENT PATENT LICENSE AGREEMENT dated as of April 28, 1998, between Ira Pastan and David J. FitzGerald (collectively, "Licensor") and Neurocrine Biosciences, Inc., a...Patent License Agreement • August 14th, 1998 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • District of Columbia
Exhibit 2.2 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (the "Agreement") is made as of May 28, 1998, by and among Neurocrine Biosciences, Inc., a Delaware corporation (the "Parent") and the persons listed on the signature page...Registration Rights Agreement • August 14th, 1998 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • California
Exhibit 2.3 6 2. Exercise of Warrant. The purchase rights represented by this Warrant are exercisable by the registered holder hereof, in whole or in part, at any time after the date hereof and prior to 4:00 p.m., La Jolla, California time, on the...Neurocrine Biosciences Inc • August 14th, 1998 • Biological products, (no disgnostic substances)
Exhibit 10.1 PUBLIC HEALTH SERVICE PATENT LICENSE AGREEMENT--EXCLUSIVE COVER PAGE For PHS internal use only: Patent License Number: L-259-97/0 Serial Numbers of Licensed Patents: A.) USPN 5,635,599 (=USSN 08/225,224); B.) USSN 08/722,258 (CIPofUSSN...Patent License Agreement • August 14th, 1998 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • District of Columbia
Exhibit 10.3 SUB-LICENSE AND DEVELOPMENT AGREEMENT THIS AGREEMENT is effective this 30th day of June 1998, by and between DOV Pharmaceutical, Inc., a New Jersey corporation, with offices at 1 Parker Plaza, Suite 1500 Fort Lee, New Jersey 07024 ("DOV")...Sub-License and Development Agreement • August 14th, 1998 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • Delaware
